Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial

Published:2015-04 Issue:9978 Volume:385 Page:1642-1652
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hersch Jolyn,Barratt Alexandra,Jansen Jesse,Irwig Les,McGeechan Kevin,Jacklyn Gemma,Thornton Hazel,Dhillon Haryana,Houssami Nehmat,McCaffery Kirsten

Funder

programme grant to the Screening and Test Evaluation Program

career development fellowship

early career fellowship

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Long-term quality of life after breast cancer: a French registry-based controlled study;Klein;Breast Cancer Res Treat,2011

2. Risk of ischemic heart disease in women after radiotherapy for breast cancer;Darby;N Engl J Med,2013

3. Pairing accountability with responsibility: the consequences of screening ‘promotion’;Thornton;Med Sci Monit,2001

4. Abolishing mammography screening programs? A view from the Swiss Medical Board;Biller-Andorno;N Engl J Med,2014

5. EMAS position statement: individualized breast cancer screening versus population-based mammography screening programmes;Depypere;Maturitas,2014

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and evaluation of a decision aid for women eligible for organized breast cancer screening according to international standards: A multi-method study;The Breast;2024-02

2. Decision-making in breast cancer screening: A qualitative exploration of the match between women’s beliefs and screening information in the Netherlands;Patient Education and Counseling;2024-01

3. Acil Servise Başvuran Hastaların Aşırı Tanısal Değerlendirme Hakkındaki Farkındalığı;Genel Tıp Dergisi;2023-12-31

4. Women's Preferences for Hypofractionated Radiation Therapy for Treatment of Early-Stage Breast Cancer: A Discrete Choice Experiment;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. (Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study);BMJ Open;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3